HPV18E6和CDK5病毒与宿主相互作用是HPV阳性宫癌的潜在治疗标
Chuanyun Xiao1, Lixin Wang2, Chichao Xia2
1Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR; Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, PR China.
Tumour virus research
|February 7, 2026
概括
人类乳头瘤病毒 (HPV) E6 coprotein 的目标是循环素依赖性激酶5 (CDK5). 一种CDK5抑制剂,CP681301,阻断HPV驱动的癌细胞生长和扩散,提供了一个新的治疗点.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 来自致癌人类乳头瘤病毒 (HPV) 的E6瘤蛋白对病毒瘤发生至关重要.
- E6促进细胞增殖和癌症进展,但其宿主点尚未完全理解.
研究的目的:
- 为了识别HPV E6coprotein的新宿主目标.
- 研究针对HPV相关癌症中的E6宿主相互作用的治疗潜力.
主要方法:
- 利用计算机辅助的分子对接和体外查来识别CDK5抑制剂.
- 使用药理抑制和基因沉默来研究CDK5-E6相互作用.
- 评估了抑制剂对癌细胞表型的影响,包括扩散,转变,迁移和入侵.
主要成果:
- 鉴定了循环素依赖性激酶5 (CDK5) 作为HPV E6.6的新型宿主标.
- 发现CDK5-E6相互作用增加了E6.6的稳定状态水平.
- 鉴定了CP681301,一种强大的CDK5抑制剂,它破坏了CDK5-E6复合体.
- 证明CP681301抑制了E6-E6AP-p53轴,抑制了癌细胞的增殖,转化,迁移和入侵.
结论:
- CDK5-E6相互作用代表了HPV驱动的瘤发生的重要途径.
- CP681301通过向CDK5-E6轴,有效地抑制HPV阳性细胞中的癌症表型.
- CDK5-E6是开发新型治疗HPV相关疾病的有希望的治疗标.
关键词:
在CDK5中使用CDK5.在CP681301中使用.宫癌是发生在宫癌的原因之一.E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E6 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7 E7通过HPV介导的致癌发生.蛋白质与蛋白质的相互作用相关概念视频
What are Viruses?
128.3K
Overview
128.3K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Chromatin Position Affects Gene Expression
24.9K
Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area.
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
24.9K
Rous Sarcoma Virus (RSV) and Cancer
6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.4K
Positive Regulator Molecules
136.5K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.5K
Position-effect Variegation
7.1K
In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
7.1K


